The ALS Association Funds Study Of New Drug With Potential To Treat Lou Gehrig's Disease
CALABASAS, Calif.--(BUSINESS WIRE)--March 15, 2006--The ALS Association (ALSA) announced funding for a safety study in monkeys of an antisense drug to lower production of a mutant protein linked to some inherited cases of amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease).